Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Guardian Pharmacy Services, Inc. (GRDN : NYSE)

• Company Description    Guardian Pharmacy Services is a long-term care pharmacy services company which provides an extensive suite of technology-enabled services designed to help residents of long-term health care facilities. Guardian Pharmacy Services is based in ATLANTA. Number of Employees: 3,400

• Price / Volume Information    Yesterday's Closing Price: $30.44 Daily Weekly Monthly 20 Day Moving Average: 282,172 shares Shares Outstanding: 63.32 (millions) Market Capitalization: $1,927.48 (millions) Beta: 0.96 52 Week High: $37.43 52 Week Low: $17.78 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 7.45% 5.18% 12 Week 20.08% 17.92% Year To Date 50.25% 29.64%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 300 GALLERIA PARKWAY SOUTH EAST SUITE 800 - ATLANTA,GA 30339 USA ph: 404-810-0089 fax: - guardianpharmacyir@westwicke.com https://guardianpharmacy.com

• General Corporate Information    Officers Fred P. Burke - President and Chief Executive Officer and Director David K. Morris - ExecutiveVicePresident;Chief Financial Officer and John Ackerman - Director William Bindley - Director Steve Cosler - Director Peer Information Guardian Pharmacy Services, Inc. (GSAC) Guardian Pharmacy Services, Inc. (CASI) Guardian Pharmacy Services, Inc. (ALCD.) Guardian Pharmacy Services, Inc. (OMNN) Guardian Pharmacy Services, Inc. (CGPI.) Guardian Pharmacy Services, Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 40145W101 SIC: 5912 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/25/26 Share - Related Items Shares Outstanding: 63.32 Most Recent Split Date: (:1) Beta: 0.96 Market Capitalization: $1,927.48 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.26 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.83 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/25/26

• Fundamental Ratios P/E Current FY Estimate: 36.67 Trailing 12 Months: 37.12 PEG Ratio: - Price Ratios Price/Book: 9.86 Price/Cash Flow: 122.03 Price / Sales: 1.39 EPS Growth vs. Year Ago Period: 109.50% vs. Previous Quarter: 5.56% Sales Growth vs. Year Ago Period: 20.05% vs. Previous Quarter: 9.61% ROE 09/30/25 - 30.29 06/30/25 - -52.41 03/31/25 - -69.36 ROA 09/30/25 - 14.88 06/30/25 - -24.17 03/31/25 - -30.92 Current Ratio 09/30/25 - 1.22 06/30/25 - 1.18 03/31/25 - 1.14 Quick Ratio 09/30/25 - 0.93 06/30/25 - 0.88 03/31/25 - 0.84 Operating Margin 09/30/25 - 3.75 06/30/25 - -6.19 03/31/25 - -6.05 Net Margin 09/30/25 - 2.90 06/30/25 - -6.90 03/31/25 - -7.02 Pre-Tax Margin 09/30/25 - 4.21 06/30/25 - -4.80 03/31/25 - -4.72 Book Value 09/30/25 - 3.09 06/30/25 - 2.84 03/31/25 - 2.58 Inventory Turnover 09/30/25 - 25.35 06/30/25 - 24.60 03/31/25 - 31.85 Debt-to-Equity 09/30/25 - 0.00 06/30/25 - 0.00 03/31/25 - 0.00 Debt-to-Capital 09/30/25 - 0.00 06/30/25 - 0.00 03/31/25 - 0.00

Powered by Zacks Investment Research ©